Delcath Systems to Present at the 34th Annual Roth Conference

2 years ago

NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the…

SPO Global Inc. Provides Update on Shandong SPO Medical (Group) Co., Ltd.

2 years ago

$SPOM - SPO Global Inc. Provides Update on Shandong SPO Medical (Group) Co., Ltd. Project -Shandong Provincial Third Hospital -…

Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention

2 years ago

A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association (JAHA),…

Pure Extracts Receives Initial Purchase Order from New Brunswick

2 years ago

VANCOUVER, British Columbia, March 10, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure…

Enzo Biochem to Present at the KeyBanc Capital Markets’ Life Sciences & MedTech Investor Forum

2 years ago

NEW YORK, NY, March 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company,…

Mustang Bio to Participate in Three March 2022 Investor Conferences

2 years ago

WORCHESTER, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on…

TOMI Fulfills Urgent Order for Multiple SteraPak Disinfection Units From Large Hong Kong-Based Real Estate Conglomerate to Combat New COVID-19 Omicron Variant Outbreak

2 years ago

FREDERICK, Md., March 10, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company that specializes…

Nuvectis Announces Upcoming Oral and Poster Presentations at the 2022 American Association for Cancer Research Meeting

2 years ago

Fort Lee, NJ, March 10, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT), (“Nuvectis” or the “Company”) a biopharmaceutical…

Panbela to Participate in the 34th Annual Roth Conference

2 years ago

MINNEAPOLIS, March 10, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for…

Allogene Therapeutics Receives FDA Fast Track Designation for its First Solid Tumor Candidate, ALLO-316 in the Treatment of Renal Cell Carcinoma

2 years ago

ALLO-316 is an allogeneic CAR T therapy candidate targeting CD70, which Has Broad Potential Application Across a Variety of Solid…